Loading clinical trials...
Loading clinical trials...
Evaluating the Use of Polymyxin B Hemoperfusion in a Randomized Controlled Trial of Adults Treated for Endotoxemia and Septic Shock
Conditions
Interventions
TORAYMYXIN PMX-20R (PMX cartridge)
Standard medical care for septic shock
Locations
40
United States
Birmingham, Alabama, United States
Tucson, Arizona, United States
Little Rock, Arkansas, United States
Loma Linda, California, United States
San Diego, California, United States
Stanford, California, United States
Start Date
June 1, 2010
Primary Completion Date
July 1, 2016
Completion Date
June 1, 2017
Last Updated
February 26, 2019
NCT07179276
NCT07383103
NCT07388628
NCT06464510
NCT07264543
NCT07230041
Lead Sponsor
Spectral Diagnostics (US) Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions